Subtype-specific impacts of clonal hematopoiesis on the risk of cerebrovascular and cardiometabolic diseases
-
By
-
Wenqiang Zhu
-
Miao Tian
-
Zihan Zhao
-
Xiaoquan Rao
-
April 28, 2026
-
Clinical Scorecard: Subtype-specific impacts of clonal hematopoiesis on the risk of cerebrovascular and cardiometabolic diseases
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | Inflammation, metabolic disturbance, vascular risk, and subtype-specific effects |
| Target Population | |
| Care Setting | |
Key Highlights
- Include associations for DNMT3A-CHIP and ASXL1-CHIP.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
- Regular monitoring of cerebrovascular health in patients with TET2-CHIP and other subtypes.
Risks
Patient & Prescribing Data
Aging individuals with clonal hematopoiesis mutations.
Management strategies should be tailored based on CHIP subtype.
Clinical Best Practices
- Monitor inflammatory markers in patients with all CHIP subtypes.
References
